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Objectives: This study tested the effectiveness of a schizophrenia care management program for family caregivers of Chinese patients with schizophrenia in Hong Kong.
Methods: A multisite controlled trial was conducted with 92 patient-caregiver dyads. They were randomly assigned to either the schizophrenia care management program or to usual care. The patients' symptoms, functioning, and length of rehospitalization and their families' perceived social support, expressed emotion, and functioning were measured at recruitment and at one month and 15 months after the intervention. Other limitations of family intervention studies are the paucity of controlled trials of needsbased interventions with a broad range of outcome measures, poor study power and high attrition rates, and insufficient interdisciplinary collaboration (2, 4) .
A few integrated multidisciplinary and multicomponent educational programs, such as a family psychoeducation group program in Hong Kong (5) and a needs-based psychosocial intervention in the United Kingdom (6), reported significant effects on families' management of patients' problem behaviors and families' general health. These programs consist of multiple supportive strategies, such as schizophrenia care education, stress management, and problem-solving skills. However, only a few family intervention studies have been conducted in Asian populations, where great importance is attached to intimate interpersonal relationships and collective behaviors among family members (1) . To address gaps in knowledge about the quality of family interventions, this trial was designed to test the effects of an interdisciplinary, needs-based schizophrenia care management program (SCMP) for family caregivers of Chinese patients with schizophrenia on patients' and families' psychosocial health and functioning.
Methods
The study was a randomized controlled trial that used a repeated-measures design. patient-caregiver dyads agreed to participate. Of these, 92 (46%) were randomly selected to take part. Based on previous studies of family intervention (4, 5) , this sample size was required to detect any significant difference between the groups at a 5% significance level with a power of 90%, and the size would allow 15% attrition (7).
Patient-caregiver dyads were eligible for the study. Caregivers were eligible for the study if they were 18 years or older, if they were the main caregiver for the relative with schizophrenia, and if they lived with the relative with schizophrenia. Patients had to be diagnosed as having schizophrenia according to DSM-IV criteria and be 18 years or older.
Caregivers who had mental illness themselves or cared for more than one relative with mental illness were excluded. After written consent of caregivers and patients had been obtained following a full explanation of the study, the participants were randomly assigned to the usual care or the SCMP group. The usual care group received routine psychiatric outpatient and family services only.
These services consisted of monthly medical consultation and treatment planning by the attending psychiatrist, nursing advice on community health care services, and brief family education (two group sessions) on patients' illness by psychiatric nurses and social workers. All patients and their family members were invited by the nurse in the clinic to participate in all of the services. The services used were freely chosen by the patientcaregiver dyads.
One researcher who was blind to the group assignment administered the pretest before the patient-caregiver dyads were randomly assigned to groups and administered two posttests at one and 15 months after the intervention. Family functioning, social support, and expressed emotion were rated with the Family Assessment Device (9), the six-item Social Support Questionnaire (10) , and the Level of Expressed Emotion Scale (11), respectively.
The patient symptoms and functioning were assessed with the Brief Psychiatric Rating Scale (12) and the Specific Level of Functioning Scale (13), respectively. The Chinese versions of these instruments were validated, indicating satisfactory reliability and validity (11, 14) . The patients' average number and length of rehospitalizations in the previous six months were also calculated. Multivariate analysis of variance (MANOVA) was performed for the outcome variables to determine the treatment effects (group {times; ×} time), followed by post-hoc Tukey's honestly significant difference analysis (that is, protected type I error). Data were analyzed on an intention-to-treat basis that maintained the advantages of random allocation (1, 2) . Participants who did not complete the program remained in the study group and were asked to complete the outcome measures at the posttests, and these data were included in the data analysis.
Results
Forty-four of the SCMP patient-caregiver dyads (96%) completed the program; only two dyads in the SCMP (4%) and one in the control group (2%) dropped out before completing the posttests. There were no significant sociodemographic or clinical differences between the two study groups and the 408 persons who did not participate in the study. [A table showing the sociodemographic and clinical characteristics of the two study groups and persons who did not participate in the study is available as an online supplement at ps.psychiatryonline.org.] There were also no significant differences on the baseline psychosocial measurement scores between the two study groups when analyzed by Student's t test.
There was a statistically significant difference between the two groups on the combined dependent variables (F=5.1, df=6 and 90, p=.003; Wilks' {Lambda; λ}= .93, partial {eta squared; η 2 }=.20). As shown in Table 1 , the results of MANOVA for the outcome measures indicated that there were statistically significant differences between the two groups regarding improvement in families' and patients' functioning, caregivers' social support, and number and length of rehospitalizations at the two posttests. The post-hoc comparisons indicated that the SCMP participants' family functioning and social support improved significantly at the two posttests but that the patients' functioning and number and length of rehospitalizations in this program improved significantly only at 15-months follow-up.
Discussion
The findings provide preliminary support for the efficacy of the SCMP in a Chinese population to improve families' and patients' functioning and rates of patients' illness relapse, as suggested in previous Western studies (6, 15) . This program, which addressed the specific cultural and familial needs of those who care for patients with schizophrenia (for example, enhancing the mutual respect and interdependence of patients and caregivers, and enhancing respect and appreciation of the caregiving role by every family member), can improve the psychosocial health condition of the whole family and decrease patients' risk of rehospitalizations over a 15-month follow-up period. Only a few studies have previously demonstrated significant long-term effects (that is, more than one year) of a family group program on both the patients' and families' psychosocial functioning (2,4) .
The findings of the study presented here clearly affirm the positive effects of a multidisciplinary schizophrenia management program designed to enhance family-oriented care. In addition, it is noteworthy that the caregivers in the SCMP reported a significant improvement in their family functioning and social support. These improvements might be a result of education, experience sharing, and skills training in the program, all of which are considered therapeutic factors in previous family studies (3, 5, 15) . In return, improved patient functioning and fewer illness relapses would likely result in better family functioning and health.
It is significant that the patients' mental condition (BPRS scores) in the two groups remained stable over the 15-month follow-up. This stability could be the result of choice of medication or patients' medication adherence; however, medication adherence was not investigated in this study and would thus provide an important subject for further research.
The late onset of illness among the patients (most aged 26-35 years) could indicate that Chinese families might hesitate and thus delay bringing their relative with mental illness in for treatment because of the perceived social stigma of mental illness in the community (4) . However, the small size of the study group limits analysis of the mediating variables to identify the therapeutic mechanisms of this family program. Usual psychiatric care was chosen as the control condition; as such, the Hawthorne effect cannot be excluded.
Conclusions
This program that was developed for family members of Chinese patients with schizophrenia and was delivered in three outpatient clinics with the multidisciplinary team was more effective than usual care. It is important to continue to implement this familyoriented intervention and to validate its long-term effects by comparing it with other family programs and by using larger samples of persons of diverse sociocultural backgrounds or other psychiatric disorders. 
